Moderna, Inc. MRNA
Set alert
234.57 USD +13.74 +6.22%
As of Nov 3, 10:53 AM ET
220.23 Day range 235.41
22.36 52-week range 245.81
- YTD
- +695.44%
- 1 year
- +841.69%
- Open
- 222.01
- Prev close
- 220.83
- Mkt cap
- 93.73B
- Vol
- 3.71M
- Avg vol
- 21.35M
- EPS
- -7.98
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 220.23
- High
- 235.41
- Forward P/E
- -48.16
- Beta
- 1.17
- Short ratio
- 1.86
- Inst. own
- 80.49%
- Dividend
- 0.00
- Ex-div date
- Earnings
- Nov 6, 2026
- 50-d avg
- 182.49
- 200-d avg
- 86.58
- 1y target
- 138.37
MAX chart
Events in this range
- Aug 1, 2025Earnings: -2.13; estimate -2.99; surprise 28.76%
- Nov 6, 2025Earnings: -0.51; estimate -1.87; surprise 72.73%
- Feb 13, 2026Earnings: -2.11; estimate -2.54; surprise 16.93%
- May 1, 2026Earnings: -3.4; estimate -4.45; surprise 23.6%
- Jul 31, 2026Earnings: -1.97; estimate -2.03; surprise 2.96%
- Sep 30, 2026Downgrade: Citigroup · Neutral → Sell
- Oct 7, 2026Rating: Morgan Stanley · Equal-Weight → Equal-Weight
- Oct 15, 2026Rating: Goldman Sachs · Neutral → Neutral
- Oct 21, 2026Rating: TD Cowen · Hold → Hold
- Oct 26, 2026Rating: Piper Sandler · Overweight → Overweight
- Oct 27, 2026Downgrade: William Blair · Outperform → Market Perform
- Nov 6, 2026Earnings: —; estimate -1.1; surprise —%
Signals (126)
| Name | Date | Ago |
|---|---|---|
| MACD: Buy Signal | Aug 17, 2026 | 2 months ago |
| RSI: Overbought | Aug 17, 2026 | 2 months ago |
| SMA: Bullish | Aug 10, 2026 | 2 months ago |
| MACD: Sell Signal | Jul 27, 2026 | 3 months ago |
| SMA: Bearish | Jul 20, 2026 | 3 months ago |
| RSI: Overbought | Jun 22, 2026 | 4 months ago |
| MACD: Buy Signal | Jun 15, 2026 | 4 months ago |
| SMA: Bullish | Jun 8, 2026 | 4 months ago |
| SMA: Bearish | May 11, 2026 | 5 months ago |
| SMA: Bullish | May 4, 2026 | 6 months ago |
| MACD: Sell Signal | Apr 27, 2026 | 6 months ago |
| SMA: Bearish | Apr 20, 2026 | 6 months ago |
| RSI: Overbought | Feb 23, 2026 | 8 months ago |
| RSI: Overbought | Jan 19, 2026 | 9 months ago |
| SMA: Bullish | Dec 1, 2025 | 11 months ago |
| SMA: Bullish | Nov 24, 2025 | 11 months ago |
| SMA: Bearish | Nov 3, 2025 | 1 year ago |
| SMA: Bearish | Nov 3, 2025 | 1 year ago |
| SMA: Bullish | Oct 27, 2025 | 1 year ago |
| SMA: Bearish | Oct 6, 2025 | 1 year ago |
Newest 20 of 126.
Analyst view
Consensus: hold
Hold
Price target (mean) 138.37 -41.0% downside
Now 234.57
- Target (low)
- 45.00
- Target (mean)
- 138.37
- Target (high)
- 251.00
Ratings (0m) 23 4 buy · 15 hold · 4 sell
- Strong buy1
- Buy3
- Hold15
- Sell2
- Strong sell2
Recommendation trend
- This month 23
- 1 month ago 23
- 2 months ago 23
Earnings and revenue estimates
Consensus for the coming quarters and fiscal years
| Period | EPS estimate | Low – high | Year ago | EPS growth | Revenue estimate | Revenue growth | Analysts |
|---|---|---|---|---|---|---|---|
| Current quarter | -1.25 | -3.28 – -0.79682 | -0.51 | -146.0% | 890.22M | -12.4% | 16 |
| Next quarter | -1.86 | -2.23 – -1.50 | -2.11 | +11.8% | 675.41M | -0.4% | 13 |
| Current year | -8.49 | -10.57 – -7.95 | -7.26 | -17.0% | 2.10B | +8.1% | 21 |
| Next year | -4.90 | -7.11 – -2.73 | -8.49 | +42.3% | 2.44B | +16.3% | 19 |
Upgrades and downgrades
The latest rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Oct 27, 2026 | William Blair | Downgrade | Outperform | Market Perform |
| Oct 26, 2026 | Piper Sandler | Reiterated | Overweight | Overweight |
| Oct 21, 2026 | TD Cowen | Maintained | Hold | Hold |
| Oct 15, 2026 | Goldman Sachs | Maintained | Neutral | Neutral |
| Oct 7, 2026 | Morgan Stanley | Maintained | Equal-Weight | Equal-Weight |
| Sep 30, 2026 | Citigroup | Downgrade | Neutral | Sell |
| Sep 3, 2026 | Rothschild & Co | Downgrade | Neutral | Sell |
| Aug 28, 2026 | Argus Research | Upgrade | Hold | Buy |
| Aug 25, 2026 | Wolfe Research | Upgrade | Underperform | Peer Perform |
| Aug 24, 2026 | Barclays | Maintained | Equal-Weight | Equal-Weight |
| Aug 21, 2026 | JP Morgan | Maintained | Underweight | Underweight |
| Aug 20, 2026 | Goldman Sachs | Maintained | Neutral | Neutral |
| Aug 20, 2026 | UBS | Maintained | Neutral | Neutral |
| Aug 20, 2026 | Morgan Stanley | Maintained | Equal-Weight | Equal-Weight |
| Aug 19, 2026 | William Blair | Upgrade | Market Perform | Outperform |
| Aug 3, 2026 | Citigroup | Maintained | Neutral | Neutral |
| Jul 21, 2026 | Goldman Sachs | Maintained | Neutral | Neutral |
| Jul 8, 2026 | Morgan Stanley | Maintained | Equal-Weight | Equal-Weight |
| Jul 7, 2026 | RBC Capital | Maintained | Sector Perform | Sector Perform |
| Jul 7, 2026 | B of A Securities | Maintained | Underperform | Underperform |
| Jun 26, 2026 | Piper Sandler | Maintained | Overweight | Overweight |
| Jun 8, 2026 | B of A Securities | Maintained | Underperform | Underperform |
| May 4, 2026 | UBS | Maintained | Neutral | Neutral |
| May 4, 2026 | Goldman Sachs | Maintained | Neutral | Neutral |
| May 4, 2026 | Evercore ISI Group | Maintained | In-Line | In-Line |
| May 4, 2026 | RBC Capital | Maintained | Sector Perform | Sector Perform |
| Apr 2, 2026 | Barclays | Maintained | Equal-Weight | Equal-Weight |
| Feb 23, 2026 | Piper Sandler | Maintained | Overweight | Overweight |
| Feb 17, 2026 | Goldman Sachs | Maintained | Neutral | Neutral |
| Feb 17, 2026 | RBC Capital | Maintained | Sector Perform | Sector Perform |